
Conference Coverage: EHA 2022 – Focus on Lymphoma
Lymphoma-specific discussions on latest research updates, therapeutic advances, and their application in clinical decision-making.

FACULTY CHAIR
Brad S. Kahl, MD
Washington University School of Medicine, St. Louis, MO, USA
Faculty Members
TBC
REPORT SNAPSHOT
- Advances in DLBCL/Aggressive B-Cell Lymphoma
- Advances in CAR T
- Advances in FL
- Advances in MCL and MZL
- Evolving Use of BTK Inhibitors in CLL
- Role of Fixed-Duration and MRD-Guided Strategies in CLL